This collaboration aims to support and accelerate clinical development of advanced and novel technologies. Aurigene Pharmaceutical Services, an India-based contract research, development, and ...
To protect itself against disease, the human body has immune cells that patrol like police officers, entering disease cells and destroying them. But some dangerous cells, including some solid tumors, ...
Dr Reddy’s Laboratories Inc, a wholly-owned subsidiary of Dr Reddy’s Laboratories, has acquired a 6.5% stake in Edity, an Israeli biotech company. The acquisition was made for $2 million in cash.
In the evolving battle against cancer, two pioneering Israeli companies, SpotItEarly and Edity Therapeutics, are using the power of bio-convergence to rewrite the rules of diagnosis and treatment. By ...
Dr. Reddy’s Laboratories has acquired 6.46 per cent of the shareholding of Edity Therapeutics Ltd, an Israel-based development stage biotechnology company. As part of the acquisition, Hyderabad-based ...
Dr. Reddy’s Laboratories has acquired 6.46% stake in Edity Therapeutics, a development stage biotechnology firm in Israel focused on a breakthrough platform technology for intracellular delivery of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results